NN-2802

N/A

Report date: 2024/08/23 09:47:30

Base Information

Drug NameNN-2802
Drug Alias NameNN-2802VB-517SLRN-517
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Stem cell growth factor receptor
TargetsStem cell growth factor receptor
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovelty Nobility Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovelty Nobility IncValenzaBio Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A